Weight loss isn’t just about cutting calories—it’s about understanding how your body works, what you eat, and the habits that ...
A new study from CSIRO, Australia's national science agency, has revealed that people who use meal plans lose more weight, ...
Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and ...
The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
Eli Lilly on Thursday said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later this year, a few months earlier than anticipated. Stream ...
Dec 23 () - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will generate about $150 ...
RENO, Nev. (KOLO) -About 12% of Americans are using weight loss drugs like Wegovy and Ozembic. They are typically prescribed ...